BCIP Life Sciences Associates, LP
- SEC CIK
- 0001702921
No open-market purchases or sales filed in the past year.
Current role at each company
- RPID Rapid Micro Biosystems, Inc.10% Owneras of May 22, 2026
- SLDB Solid Biosciences Inc.10% Owneras of Feb 21, 2025
- NAMS NewAmsterdam Pharma Co N.V.10% Owneras of Dec 17, 2024
- ANNX Annexon, Inc.10% Owneras of May 30, 2023
- XLO Xilio Therapeutics, Inc.10% Owneras of Dec 10, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists BCIP Life Sciences Associates, LP as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RPID Rapid Micro Biosystems, Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 22, 2026 (view filing)4:30 PM ET | May 20 | 2 days | Bain Capital Life Sciences Fund, L.P. and 3 others10% Owner | PPurchaseClass A Common Stock | +4.39M | – | – | –1.46M after | Derivative3 lots |
| Jul 21, 2021 (view filing)4:40 PM ET | Jul 19 | 2 days | Schwartz Jeffrey Lawrence and 5 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +100.0K | $20.00 | +$2.00M | +1.2%8.43M after |
SLDB Solid Biosciences Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2025 (view filing)5:48 PM ET | Feb 19 | 2 days | BCIP Life Sciences Associates, LP and 9 others10% Owner | PPurchase | +1.00M | $4.03 | +$4.03M | +24.8%5.03M after | |
| Feb 21, 2025 (view filing)5:48 PM ET | Feb 19 | 2 days | BCIP Life Sciences Associates, LP and 9 others10% Owner | PPurchase | +6.44M | $4.03 | +$26.0M | –6.44M after | Derivative |
NAMS NewAmsterdam Pharma Co N.V.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2024 (view filing)5:05 PM ET | Dec 13 | 4 days | BCIP Life Sciences Associates, LP and 9 others10% Owner | PPurchase | +1.63M | $24.50 | +$40.0M | –1.63M after | Derivative |
ANNX Annexon, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 30, 2023 (view filing)9:54 PM ET | May 25 | 5 days | Bain Capital Life Sciences Fund, L.P. and 3 others10% Owner | PPurchase | +300.0K | $2.13 | +$639.7K | +5.6%5.70M after |
XLO Xilio Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2021 (view filing)8:33 PM ET | Dec 8-10 | 2 days | BCIP Life Sciences Associates, LP and 5 others10% Owner | PPurchase | +42.5K | $9.66 | +$410.2K | +1.5%2.81M after | 4 lots |